Organization
Alberta Health Services Cancer Control Alberta
30 clinical trials
Clinical trial
A Randomized Controlled Trial of Chemo-Radiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail Patients With Newly Diagnosed GlioblastomaStatus: Recruiting, Estimated PCD: 2032-06-01
Clinical trial
A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home EnvironmentStatus: Recruiting, Estimated PCD: 2024-05-01
Clinical trial
Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer (DARTS): A Prospective Phase II Trial Evaluating Local Control of Adaptive Dose-escalated RadiotherapyStatus: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
A Phase II Study of Fluorine-18 (18F)-Labeled PSMA-1007 in Patients With Known or Suspected Metastatic Prostatic CarcinomaStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
A Phase I/II Study of Gallium-68 HA-DOTATATE ([68]Ga-HA-DOTATATE) in Patients With Known or Suspected Somatostatin Receptor Positive TumoursStatus: Recruiting, Estimated PCD: 2031-12-01
Clinical trial
Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the ProstateStatus: Terminated, Estimated PCD: 2020-11-01
Clinical trial
Loratadine for the Prevention of Bone Pain Caused by Granulocyte Colony Stimulating Factor (G-CSF) During Stem Cell MobilizationStatus: Not yet recruiting, Estimated PCD: 2026-11-01
Clinical trial
A Multicentre, Open-label Phase II Study of Nab-paclitaxel in Combination With Gemcitabine + Cisplatin as First Line Treatment in Patients With Unresectable Biliary Tract CancerStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
A Multi-Centre, Single Arm, Phase 2 Trial of Pembrolizumab in Treatment Naïve Patients With Poor-Prognosis Carcinoma of Unknown Primary SiteStatus: Active (not recruiting), Estimated PCD: 2023-06-16
Clinical trial
Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014Status: Active (not recruiting), Estimated PCD: 2025-12-01
Clinical trial
Biomarker and Tumor Cell Culture-Driven Pilot Trial for Treatment of Recurrent GlioblastomaStatus: Recruiting, Estimated PCD: 2027-07-01
Clinical trial
An Open-label Phase II Study of Lutetium-177 [DOTA0, Tyr3] Octreotate (Lu-DOTA-TATE) Treatment in Patients With Somatostatin Receptor Positive TumoursStatus: Recruiting, Estimated PCD: 2033-12-01
Clinical trial
A Phase 2, Open-label Study to Evaluate Graft-vs-host Disease Prophylaxis With High Dose Thymoglobulin, Methotrexate, and Low-dose Cyclosporine in Comparison to Historical/Concurrent Controls Who Received Low Dose Thymoglobulin, Methotrexate, and High-dose CyclosporineStatus: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
A Study to Evaluate the Efficacy and Safety of Methotrexate in Immune Related Arthritis or ArthralgiasStatus: Not yet recruiting, Estimated PCD: 2026-01-01
Clinical trial
The LATENT Trial: Lytic Activation To Enhance Neoantigen-directed Therapy A Study to Evaluate the Feasibility and Efficacy of the Combined Use of Avelumab With Valproic Acid for the Treatment of Virus-associated CancerStatus: Active (not recruiting), Estimated PCD: 2022-03-30
Clinical trial
Feasibility and Efficacy of Intravenous Ferric Derisomaltose to Correct Pre-operative Iron-deficiency Anemia in Patients Undergoing Gynecologic Oncology Surgery: a Pilot Randomized Double Blinded Parallel Group Placebo-controlled StudyStatus: Not yet recruiting, Estimated PCD: 2025-09-30
Clinical trial
A Randomized Phase II Study of Temozolomide Monotherapy or in Combination With Olaparib in Patients With METHYLATED 06-Methylguanine-DNA Methyltransferase (MGMT) Pre-Treated Triple Negative Breast Cancer (TNBC)Status: Not yet recruiting, Estimated PCD: 2027-07-01
Clinical trial
A Study to Evaluate the Efficacy and Safety Hydroxychloroquine in Immune Related Arthritis or ArthralgiasStatus: Recruiting, Estimated PCD: 2025-07-01
Clinical trial
A Phase I-II Study of Niacin in Patients With Newly Diagnosed Glioblastoma Receiving Concurrent Radiotherapy and Temozolomide Followed by Monthly TemozolomideStatus: Recruiting, Estimated PCD: 2026-01-01
Clinical trial
Infusional Gemcitabine and High-dose Melphalan (HDM) Conditioning Prior to (ASCT) Autologous Stem Cell Transplantation for Patients With Relapsed/Refractory LymphomaStatus: Terminated, Estimated PCD: 2023-01-01
Clinical trial
A Study to Evaluate the Efficacy of Propranolol in Boosting Immunotherapy in Hepatocellular Carcinoma, Cholangiocarcinoma and Pancreatic AdenocarcinomaStatus: Not yet recruiting, Estimated PCD: 2025-10-01
Clinical trial
PRe-operative ESTradiOl Window of Opportunity Study in Post-Menopausal Women With Newly Diagnosed ER Positive Breast CancerStatus: Active (not recruiting), Estimated PCD: 2018-07-30
Clinical trial
An Interventional, Randomized Phase II Study Investigating the Efficacy of Immune Checkpoint Inhibitors While Corticosteroid Therapy is Required for Patients With Symptomatic Brain Metastases.Status: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
A Phase I Dose Escalation Trial to Determine if Imatinib Treatment Restores Sodium Iodide Symporter Function and Sensitivity to Radioiodine Treatment in Metastatic Thyroid Cancer PatientsStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Randomized Controlled Trial of Tamoxifen Versus Etoposide for Patients With First Recurrence of Glioblastoma MultiformeStatus: Recruiting, Estimated PCD: 2026-08-01
Clinical trial
Prophylactic Oral Mesalamine for the Prevention of Immune-Related Colitis in Patients Treated With Ipilimumab/NivolumabStatus: Not yet recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Study to Evaluate the Safety and Feasibility of Irinotecan, Trifluridine/Tipiracil (TAS-102), and Oxaliplatin (iTTo) for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaStatus: Completed, Estimated PCD: 2023-07-07
Clinical trial
An Interventional, Single-arm, Open-label Phase I/II Study Investigating the Efficacy and Safety of Anti-PD1 Immunotherapy for the Treatment of Patients With Cutaneous T-cell Lymphoma (Mycosis Fungoides)Status: Not yet recruiting, Estimated PCD: 2025-02-01
Clinical trial
A Study to Evaluate the Safety and Feasibility of the Combined Use of Nivolumab With Pemetrexed for the Treatment of Advanced Squamous Cell Carcinoma of the Head and NeckStatus: Completed, Estimated PCD: 2023-04-14
Clinical trial
UNresectable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy. A Study to Evaluate the Efficacy and Safety of the Combined Use of Avelumab With Radiation Therapy for the Treatment of Unresectable Cutaneous Squamous Cell CarcinomaStatus: Active (not recruiting), Estimated PCD: 2022-11-21